Loading…

Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells

We examined the effects of dexamethasone (Dex), a synthetic glucocorticoid, on the formation of mineralized bone nodules and the gene expressions of the late osteoblastic markers, bone sialoprotein (BSP), osteocalcin (OC), and osteopontin (OPN) in mature osteoblast ROS17/2.8 cells. Treatment of ROS1...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 2007-10, Vol.362 (2), p.368-373
Main Authors: Mikami, Yoshikazu, Omoteyama, Kazuki, Kato, Shigeyuki, Takagi, Minoru
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753
cites cdi_FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753
container_end_page 373
container_issue 2
container_start_page 368
container_title Biochemical and biophysical research communications
container_volume 362
creator Mikami, Yoshikazu
Omoteyama, Kazuki
Kato, Shigeyuki
Takagi, Minoru
description We examined the effects of dexamethasone (Dex), a synthetic glucocorticoid, on the formation of mineralized bone nodules and the gene expressions of the late osteoblastic markers, bone sialoprotein (BSP), osteocalcin (OC), and osteopontin (OPN) in mature osteoblast ROS17/2.8 cells. Treatment of ROS17/2.8 cells with Dex resulted in the induction of mineralization accompanied with increasing BSP and OC expressions. Previous reports have demonstrated that BSP and OC expressions are regulated by Runx2. Then, we hypothesized that Dex might promote osteoblastic differentiation and mineralization on ROS17/2.8 by Runx2. In this study, no effect was observed in mRNA and protein expression of Runx2. However, the transcriptional activity of Runx2 was enhanced by Dex treatment. Furthermore, the Dex-induced BSP and OC expressions decreased after the transfection of Runx2 small-interfering RNAs (siRNAs). These results suggested that the enhancement of Runx2 transcriptional activity by Dex treatment may be followed by the activation of osteoblast marker genes, such as BSP and OC to thereby produce a bone-specific matrix that subsequently becomes mineralized.
doi_str_mv 10.1016/j.bbrc.2007.07.192
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68230710</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006291X07016658</els_id><sourcerecordid>20130020</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753</originalsourceid><addsrcrecordid>eNqFkU1rFTEUhoMo9rb6B1xIVu5mepLcmcyAGylVC4WCH-AuZJITm-vM5JpkSvUX-LPN9F7QlcKBwMtzXsJ5CHnBoGbA2vNdPQzR1BxA1mVYzx-RDYMeKs5g-5hsAKCteM--nJDTlHYAjG3b_ik5YVKClJJvyK-r2S4m-zuk6ByanGhw1OK9njDf6hRmpGGm-Rbp5GeMevQ_dfYl0rN9iEPKGIZRp-wN_YqFx_t9xJQKlKif6aTzEv_mqtF_Q_rh5iOT57zuqMFxTM_IE6fHhM-P7xn5_Pby08X76vrm3dXFm-vKbBuWq170KPggrTV9ywVvxFZ3gqPtus4JDsYxLW3TDyU3DrVzbSO5HICja0A24oy8OvTuY_i-YMpq8mn9gZ4xLEm1HRcgGfwX5MAEAF9BfgBNDClFdGof_aTjD8VAraLUTq2i1CpKlSmiytLLY_syTGj_rBzNFOD1AcByjDuPUSXjcTZofSyalA3-X_2_AX2WphQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20130020</pqid></control><display><type>article</type><title>Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells</title><source>ScienceDirect Journals</source><creator>Mikami, Yoshikazu ; Omoteyama, Kazuki ; Kato, Shigeyuki ; Takagi, Minoru</creator><creatorcontrib>Mikami, Yoshikazu ; Omoteyama, Kazuki ; Kato, Shigeyuki ; Takagi, Minoru</creatorcontrib><description>We examined the effects of dexamethasone (Dex), a synthetic glucocorticoid, on the formation of mineralized bone nodules and the gene expressions of the late osteoblastic markers, bone sialoprotein (BSP), osteocalcin (OC), and osteopontin (OPN) in mature osteoblast ROS17/2.8 cells. Treatment of ROS17/2.8 cells with Dex resulted in the induction of mineralization accompanied with increasing BSP and OC expressions. Previous reports have demonstrated that BSP and OC expressions are regulated by Runx2. Then, we hypothesized that Dex might promote osteoblastic differentiation and mineralization on ROS17/2.8 by Runx2. In this study, no effect was observed in mRNA and protein expression of Runx2. However, the transcriptional activity of Runx2 was enhanced by Dex treatment. Furthermore, the Dex-induced BSP and OC expressions decreased after the transfection of Runx2 small-interfering RNAs (siRNAs). These results suggested that the enhancement of Runx2 transcriptional activity by Dex treatment may be followed by the activation of osteoblast marker genes, such as BSP and OC to thereby produce a bone-specific matrix that subsequently becomes mineralized.</description><identifier>ISSN: 0006-291X</identifier><identifier>EISSN: 1090-2104</identifier><identifier>DOI: 10.1016/j.bbrc.2007.07.192</identifier><identifier>PMID: 17707772</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alkaline Phosphatase - metabolism ; Animals ; Anthraquinones - chemistry ; Blotting, Western ; Calcification, Physiologic - drug effects ; Calcium - metabolism ; Cell Differentiation - drug effects ; Cell Differentiation - genetics ; Cell Line, Tumor ; Core Binding Factor Alpha 1 Subunit - genetics ; Core Binding Factor Alpha 1 Subunit - metabolism ; Dexamethasone ; Dexamethasone - pharmacology ; Dose-Response Relationship, Drug ; Gene Expression - drug effects ; Glucocorticoids - pharmacology ; Histocytochemistry ; Integrin-Binding Sialoprotein ; Mineralization ; Osteoblasts - drug effects ; Osteoblasts - metabolism ; Osteocalcin - genetics ; Osteocalcin - metabolism ; Osteopontin - genetics ; Osteopontin - metabolism ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; RNA, Small Interfering - genetics ; ROS17/2.8 ; Runx2 ; Sialoglycoproteins - genetics ; Sialoglycoproteins - metabolism ; Time Factors ; Transfection</subject><ispartof>Biochemical and biophysical research communications, 2007-10, Vol.362 (2), p.368-373</ispartof><rights>2007 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753</citedby><cites>FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17707772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikami, Yoshikazu</creatorcontrib><creatorcontrib>Omoteyama, Kazuki</creatorcontrib><creatorcontrib>Kato, Shigeyuki</creatorcontrib><creatorcontrib>Takagi, Minoru</creatorcontrib><title>Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells</title><title>Biochemical and biophysical research communications</title><addtitle>Biochem Biophys Res Commun</addtitle><description>We examined the effects of dexamethasone (Dex), a synthetic glucocorticoid, on the formation of mineralized bone nodules and the gene expressions of the late osteoblastic markers, bone sialoprotein (BSP), osteocalcin (OC), and osteopontin (OPN) in mature osteoblast ROS17/2.8 cells. Treatment of ROS17/2.8 cells with Dex resulted in the induction of mineralization accompanied with increasing BSP and OC expressions. Previous reports have demonstrated that BSP and OC expressions are regulated by Runx2. Then, we hypothesized that Dex might promote osteoblastic differentiation and mineralization on ROS17/2.8 by Runx2. In this study, no effect was observed in mRNA and protein expression of Runx2. However, the transcriptional activity of Runx2 was enhanced by Dex treatment. Furthermore, the Dex-induced BSP and OC expressions decreased after the transfection of Runx2 small-interfering RNAs (siRNAs). These results suggested that the enhancement of Runx2 transcriptional activity by Dex treatment may be followed by the activation of osteoblast marker genes, such as BSP and OC to thereby produce a bone-specific matrix that subsequently becomes mineralized.</description><subject>Alkaline Phosphatase - metabolism</subject><subject>Animals</subject><subject>Anthraquinones - chemistry</subject><subject>Blotting, Western</subject><subject>Calcification, Physiologic - drug effects</subject><subject>Calcium - metabolism</subject><subject>Cell Differentiation - drug effects</subject><subject>Cell Differentiation - genetics</subject><subject>Cell Line, Tumor</subject><subject>Core Binding Factor Alpha 1 Subunit - genetics</subject><subject>Core Binding Factor Alpha 1 Subunit - metabolism</subject><subject>Dexamethasone</subject><subject>Dexamethasone - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Gene Expression - drug effects</subject><subject>Glucocorticoids - pharmacology</subject><subject>Histocytochemistry</subject><subject>Integrin-Binding Sialoprotein</subject><subject>Mineralization</subject><subject>Osteoblasts - drug effects</subject><subject>Osteoblasts - metabolism</subject><subject>Osteocalcin - genetics</subject><subject>Osteocalcin - metabolism</subject><subject>Osteopontin - genetics</subject><subject>Osteopontin - metabolism</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>RNA, Small Interfering - genetics</subject><subject>ROS17/2.8</subject><subject>Runx2</subject><subject>Sialoglycoproteins - genetics</subject><subject>Sialoglycoproteins - metabolism</subject><subject>Time Factors</subject><subject>Transfection</subject><issn>0006-291X</issn><issn>1090-2104</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkU1rFTEUhoMo9rb6B1xIVu5mepLcmcyAGylVC4WCH-AuZJITm-vM5JpkSvUX-LPN9F7QlcKBwMtzXsJ5CHnBoGbA2vNdPQzR1BxA1mVYzx-RDYMeKs5g-5hsAKCteM--nJDTlHYAjG3b_ik5YVKClJJvyK-r2S4m-zuk6ByanGhw1OK9njDf6hRmpGGm-Rbp5GeMevQ_dfYl0rN9iEPKGIZRp-wN_YqFx_t9xJQKlKif6aTzEv_mqtF_Q_rh5iOT57zuqMFxTM_IE6fHhM-P7xn5_Pby08X76vrm3dXFm-vKbBuWq170KPggrTV9ywVvxFZ3gqPtus4JDsYxLW3TDyU3DrVzbSO5HICja0A24oy8OvTuY_i-YMpq8mn9gZ4xLEm1HRcgGfwX5MAEAF9BfgBNDClFdGof_aTjD8VAraLUTq2i1CpKlSmiytLLY_syTGj_rBzNFOD1AcByjDuPUSXjcTZofSyalA3-X_2_AX2WphQ</recordid><startdate>20071019</startdate><enddate>20071019</enddate><creator>Mikami, Yoshikazu</creator><creator>Omoteyama, Kazuki</creator><creator>Kato, Shigeyuki</creator><creator>Takagi, Minoru</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20071019</creationdate><title>Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells</title><author>Mikami, Yoshikazu ; Omoteyama, Kazuki ; Kato, Shigeyuki ; Takagi, Minoru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Alkaline Phosphatase - metabolism</topic><topic>Animals</topic><topic>Anthraquinones - chemistry</topic><topic>Blotting, Western</topic><topic>Calcification, Physiologic - drug effects</topic><topic>Calcium - metabolism</topic><topic>Cell Differentiation - drug effects</topic><topic>Cell Differentiation - genetics</topic><topic>Cell Line, Tumor</topic><topic>Core Binding Factor Alpha 1 Subunit - genetics</topic><topic>Core Binding Factor Alpha 1 Subunit - metabolism</topic><topic>Dexamethasone</topic><topic>Dexamethasone - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Gene Expression - drug effects</topic><topic>Glucocorticoids - pharmacology</topic><topic>Histocytochemistry</topic><topic>Integrin-Binding Sialoprotein</topic><topic>Mineralization</topic><topic>Osteoblasts - drug effects</topic><topic>Osteoblasts - metabolism</topic><topic>Osteocalcin - genetics</topic><topic>Osteocalcin - metabolism</topic><topic>Osteopontin - genetics</topic><topic>Osteopontin - metabolism</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>RNA, Small Interfering - genetics</topic><topic>ROS17/2.8</topic><topic>Runx2</topic><topic>Sialoglycoproteins - genetics</topic><topic>Sialoglycoproteins - metabolism</topic><topic>Time Factors</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikami, Yoshikazu</creatorcontrib><creatorcontrib>Omoteyama, Kazuki</creatorcontrib><creatorcontrib>Kato, Shigeyuki</creatorcontrib><creatorcontrib>Takagi, Minoru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biochemical and biophysical research communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikami, Yoshikazu</au><au>Omoteyama, Kazuki</au><au>Kato, Shigeyuki</au><au>Takagi, Minoru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells</atitle><jtitle>Biochemical and biophysical research communications</jtitle><addtitle>Biochem Biophys Res Commun</addtitle><date>2007-10-19</date><risdate>2007</risdate><volume>362</volume><issue>2</issue><spage>368</spage><epage>373</epage><pages>368-373</pages><issn>0006-291X</issn><eissn>1090-2104</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>We examined the effects of dexamethasone (Dex), a synthetic glucocorticoid, on the formation of mineralized bone nodules and the gene expressions of the late osteoblastic markers, bone sialoprotein (BSP), osteocalcin (OC), and osteopontin (OPN) in mature osteoblast ROS17/2.8 cells. Treatment of ROS17/2.8 cells with Dex resulted in the induction of mineralization accompanied with increasing BSP and OC expressions. Previous reports have demonstrated that BSP and OC expressions are regulated by Runx2. Then, we hypothesized that Dex might promote osteoblastic differentiation and mineralization on ROS17/2.8 by Runx2. In this study, no effect was observed in mRNA and protein expression of Runx2. However, the transcriptional activity of Runx2 was enhanced by Dex treatment. Furthermore, the Dex-induced BSP and OC expressions decreased after the transfection of Runx2 small-interfering RNAs (siRNAs). These results suggested that the enhancement of Runx2 transcriptional activity by Dex treatment may be followed by the activation of osteoblast marker genes, such as BSP and OC to thereby produce a bone-specific matrix that subsequently becomes mineralized.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17707772</pmid><doi>10.1016/j.bbrc.2007.07.192</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-291X
ispartof Biochemical and biophysical research communications, 2007-10, Vol.362 (2), p.368-373
issn 0006-291X
1090-2104
language eng
recordid cdi_proquest_miscellaneous_68230710
source ScienceDirect Journals
subjects Alkaline Phosphatase - metabolism
Animals
Anthraquinones - chemistry
Blotting, Western
Calcification, Physiologic - drug effects
Calcium - metabolism
Cell Differentiation - drug effects
Cell Differentiation - genetics
Cell Line, Tumor
Core Binding Factor Alpha 1 Subunit - genetics
Core Binding Factor Alpha 1 Subunit - metabolism
Dexamethasone
Dexamethasone - pharmacology
Dose-Response Relationship, Drug
Gene Expression - drug effects
Glucocorticoids - pharmacology
Histocytochemistry
Integrin-Binding Sialoprotein
Mineralization
Osteoblasts - drug effects
Osteoblasts - metabolism
Osteocalcin - genetics
Osteocalcin - metabolism
Osteopontin - genetics
Osteopontin - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - genetics
RNA, Messenger - metabolism
RNA, Small Interfering - genetics
ROS17/2.8
Runx2
Sialoglycoproteins - genetics
Sialoglycoproteins - metabolism
Time Factors
Transfection
title Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T04%3A24%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inductive%20effects%20of%20dexamethasone%20on%20the%20mineralization%20and%20the%20osteoblastic%20gene%20expressions%20in%20mature%20osteoblast-like%20ROS17/2.8%20cells&rft.jtitle=Biochemical%20and%20biophysical%20research%20communications&rft.au=Mikami,%20Yoshikazu&rft.date=2007-10-19&rft.volume=362&rft.issue=2&rft.spage=368&rft.epage=373&rft.pages=368-373&rft.issn=0006-291X&rft.eissn=1090-2104&rft_id=info:doi/10.1016/j.bbrc.2007.07.192&rft_dat=%3Cproquest_cross%3E20130020%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-939e32b7ddc96232534a832ed888f320cf1a7d59b34acfeaff65727b02ef50753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20130020&rft_id=info:pmid/17707772&rfr_iscdi=true